Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma

Table 1

Association of miR-17 expression in human glioma tissues with different clinicopathological features.

Clinicopathological features	No. of cases	miR-17 expression		𝑃
		High (𝑛, %)	Low (𝑛, %)
WHO grade
I	18	0 (0)	18 (100.0)	0.006
II	12	1 (8.3)	11 (91.7)
III	32	20 (62.5)	12 (37.5)
IV	46	39 (84.8)	7 (15.2)
Age
<50	42	18 (42.9)	24 (57.1)	NS
≥50	66	42 (63.6)	24 (36.4)
Gender
Male	64	39 (60.9)	25 (39.1)	NS
Female	44	21 (47.7)	23 (52.3)
Tumor size
≥6 cm	75	40 (53.3)	35 (46.7)	NS
<6 cm	33	20 (60.6)	13 (39.4)
KPS
<90	78	54 (69.2)	24 (30.8)	0.01
≥90	30	6 (20.0)	24 (80.0)